Literature DB >> 20435195

Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study.

Alanna M Chamberlain1, Sunil K Agarwal, Marietta Ambrose, Aaron R Folsom, Elsayed Z Soliman, Alvaro Alonso.   

Abstract

BACKGROUND: The metabolic syndrome (MetSyn) has been implicated in the development of atrial fibrillation (AF); however, knowledge of this association among blacks is limited.
METHODS: We determined the risk of incident AF through December 2005 in relation to baseline (1987-1989) MetSyn status in 15,094 participants of the Atherosclerosis Risk in Communities study.
RESULTS: Over a mean follow-up of 15.4 years, 1,238 incident AF events were identified. The hazard ratio (HR) for AF among individuals with, compared to those without, the MetSyn was 1.67 (95% CI 1.49-1.87), and associations did not differ by race (P for interaction = .73). The population attributable risk of AF from the MetSyn was 22%. The multivariable-adjusted HRs (95% CI) for each MetSyn component were 1.95 (1.72-2.21) (elevated blood pressure), 1.40 (1.23-1.59) (elevated waist circumference), 1.20 (1.06-1.37) (low high-density lipoprotein cholesterol), 1.16 (1.03-1.31) (impaired fasting glucose), and 0.95 (0.84-1.09) (elevated triglycerides). A monotonically increasing risk of AF with increasing number of MetSyn components was observed, with an HR of 4.40 (95% CI 3.25-5.94) for those with all 5 MetSyn components compared to those with 0 components.
CONCLUSION: In this large cohort, the MetSyn and most of its components were associated with a higher risk of AF in both blacks and whites. Given the high prevalence of the MetSyn, strategies to prevent its development or to control individual components may reduce the burden of AF. 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20435195      PMCID: PMC2864775          DOI: 10.1016/j.ahj.2010.02.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  30 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

3.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

Authors:  J A Baecke; J Burema; J E Frijters
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

4.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

5.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.

Authors:  Emelia J Benjamin; Kenneth M Rice; Dan E Arking; Arne Pfeufer; Charlotte van Noord; Albert V Smith; Renate B Schnabel; Joshua C Bis; Eric Boerwinkle; Moritz F Sinner; Abbas Dehghan; Steven A Lubitz; Ralph B D'Agostino; Thomas Lumley; Georg B Ehret; Jan Heeringa; Thor Aspelund; Christopher Newton-Cheh; Martin G Larson; Kristin D Marciante; Elsayed Z Soliman; Fernando Rivadeneira; Thomas J Wang; Gudny Eiríksdottir; Daniel Levy; Bruce M Psaty; Man Li; Alanna M Chamberlain; Albert Hofman; Ramachandran S Vasan; Tamara B Harris; Jerome I Rotter; W H Linda Kao; Sunil K Agarwal; Bruno H Ch Stricker; Ke Wang; Lenore J Launer; Nicholas L Smith; Aravinda Chakravarti; André G Uitterlinden; Philip A Wolf; Nona Sotoodehnia; Anna Köttgen; Cornelia M van Duijn; Thomas Meitinger; Martina Mueller; Siegfried Perz; Gerhard Steinbeck; H-Erich Wichmann; Kathryn L Lunetta; Susan R Heckbert; Vilmundur Gudnason; Alvaro Alonso; Stefan Kääb; Patrick T Ellinor; Jacqueline C M Witteman
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

6.  Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency.

Authors:  U Nägele; E O Hägele; G Sauer; E Wiedemann; P Lehmann; A W Wahlefeld; W Gruber
Journal:  J Clin Chem Clin Biochem       Date:  1984-02

Review 7.  Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target.

Authors:  Jeff S Healey; Stuart J Connolly
Journal:  Am J Cardiol       Date:  2003-05-22       Impact factor: 2.778

8.  Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913.

Authors:  H Eriksson; K Caidahl; B Larsson; L O Ohlson; L Welin; L Wilhelmsen; K Svärdsudd
Journal:  Eur Heart J       Date:  1987-09       Impact factor: 29.983

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

View more
  71 in total

1.  Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study.

Authors:  Rachel R Huxley; Alvaro Alonso; Faye L Lopez; Kristian B Filion; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; James S Pankow; Elizabeth Selvin
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

4.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

5.  Obesity begets atrial fibrillation: a contemporary summary.

Authors:  Jared W Magnani; Elaine M Hylek; Caroline M Apovian
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

6.  A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans.

Authors:  Leonard Ilkhanoff; Dan E Arking; Rozenn N Lemaitre; Alvaro Alonso; Lin Y Chen; Peter Durda; Stephanie E Hesselson; Kathleen F Kerr; Jared W Magnani; Gregory M Marcus; Renate B Schnabel; J Gustav Smith; Elsayed Z Soliman; Alexander P Reiner; Nona Sotoodehnia
Journal:  J Cardiovasc Electrophysiol       Date:  2014-08-25

Review 7.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

8.  Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.

Authors:  Konstantinos N Aronis; Na Wang; Caroline L Phillips; Emelia J Benjamin; Gregory M Marcus; Anne B Newman; Nicolas Rodondi; Suzanne Satterfield; Tamara B Harris; Jared W Magnani
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

9.  Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.

Authors:  Lars Frost; Emelia J Benjamin; Morten Fenger-Grøn; Asger Pedersen; Anne Tjønneland; Kim Overvad
Journal:  Obesity (Silver Spring)       Date:  2014-02-18       Impact factor: 5.002

10.  High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Kristian B Filion; Sunil K Agarwal; Christie M Ballantyne; Maria Eberg; Ron C Hoogeveen; Rachel R Huxley; Laura R Loehr; Vijay Nambi; Elsayed Z Soliman; Alvaro Alonso
Journal:  Am Heart J       Date:  2014-10-22       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.